BioCardia (BCDA) 10-K/A2022 FY Annual report (amended)

Filed: 1 May 23, 5:04pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Good

New words: accredited, advice, advisor, AIVA, Algorithmic, ALZA, Amgen, Andy, anonymously, apnea, Apneon, App, Archive, Attention, attestation, Attorney, Auburn, Avenda, AVIA, Baxter, beer, began, Biochemistry, Biovest, Blank, bring, brought, BSLF, cal, cancer, Cantor, catheter, Celladon, character, cliff, compatibility, compensatory, Compensia, complementary, concept, constructive, counterclaim, deleted, Diego, diligently, dismissed, disruptive, diverse, diversity, divesture, Durect, Edward, Eiger, encourage, EndoTex, enrichment, ENT, error, estate, excessive, external, fiduciary, filtered, Fitzgerald, foremost, Frontiere, Funder, gender, Guidant, hedge, hostile, illegal, imposition, incumbent, Inline, Insider, Instance, Instruction, Intersect, Inventive, invite, ix, Jim, Johnson, Judson, kidney, Kimberly, Krisztina, Kyle, Lincoln, Linkbase, Lowell, mail, Maryland, merged, Mettler, Mexico, Montgomery, month, Mutual, narrative, nationwide, Neumentum, nominee, nVision, obstructive, Oncocyclist, Oregon, orientation, Park, philanthropic, PKF, postal, proper, prostate, qualification, question, Rainin, reliance, Remedyne, remit, remitted, Renomination, representation, repricing, ReVENT, Revolution, role, Roper, Sarna, save, Schema, Scott, Sea, Seaboard, Sera, settlement, sexual, sleep, software, Soquel, sought, Specimen, Star, Studio, Sunnyvale, Taxonomy, thereunder, threatening, Toledo, TransCore, Troy, unchanged, unduly, unjust, unsuitable, Upchurch, VasoRx, Venice, veteran, vii, viii, VP, Wesley, women, worthy, writing, XBRL, Zsebo

Removed: acquisition, adversely, advertising, authority, cardo, condition, conjunction, converted, cost, determine, developed, fee, focused, history, initial, joint, letter, marketing, materially, maximum, measure, minimum, Morgan, note, notice, obtained, operating, orthopedic, outpatient, perform, position, post, rate, read, receipt, reconstructive, Rubin, sector, secured, spinal, Steven, Subbarao, substantial, surgery, surgical, terminated, Uppaluri, voluntarily, work

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated BCDA transcripts

BCDA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 31.1

Certification of Principal Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Peter Altman, certify that:

1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of BioCardia, Inc.; and

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: May 1, 2023

	/s/ Peter Altman
	Name: Peter Altman
	Title: President and Chief Executive Officer